In light of increasing rates of both obesity and overweight in the United States, todays approval addresses an unmet medical need. Approximately 70% of Americans are overweight or obese, according to the FDA, and a worrying report published by the World Obesity Federation this year projected that more than half of the worlds population could be overweight or obese by 2035
While its essential to continue with proven, disease-modifying treatments to effectively manage the autoimmune disorder, GLP-1 agonists can offer added support, especially for addressing residual inflammation or metabolic issues
Some people also prefer alternative delivery methods, and the peptide injection pen guide explores pen-based systems that simplify the injection process
Zhonghua Zheng Xing Wai Ke Za Zhi 30(2):111117 Wang Z et al (2014) Pyrroloquinoline quinone protects mouse brain endothelial cells from high glucose-induced damage in vitro
So it makes sense that newly postpartum women are asking about GLP-1s
Some patients find that evening dosing helps them manage daytime nausea, whilst others find morning administration allows them to eat lighter evening meals, which may further support weight management goals